Trade Report: The Investors Buy Shares of Monsanto Co. (MON) on Weakness on Insider Selling

The Investors Buy Shares of Monsanto Co. (MON) on Weakness on Insider Selling

Traders bought shares of Monsanto Co. (NYSE:MON) on weakness during trading hours on Friday following insider selling activity. $135.47 million flowed into the stock on the tick-up and $53.93 million flowed out of the stock on the tick-down, for a money net flow of $81.54 million into the stock. Of all equities tracked, Monsanto had the highest net in-flow for the day. Monsanto traded down ($0.43) for the day and closed at $102.11Specifically, Director Charles S. Mcmillan purchased 3,500 shares of the company’s stock in a transaction dated Monday, October 10th. The shares were purchased at an average price of $103.23 per share, for a total transaction of $361,305.00. Following the transaction, the director now owns 64,009 shares of the company’s stock, valued at $6,607,649.07. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Steven Mizell sold 310 shares of the business’s stock in a transaction that occurred on Monday, October 10th. The stock was sold at an average price of $103.09, for a total transaction of $31,957.90. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by insiders.

A number of research analysts have recently issued reports on MON shares. Goldman Sachs Group Inc. set a $92.00 price target on shares of Monsanto and gave the stock a “sell” rating in a research report on Monday, June 27th. Vetr upgraded shares of Monsanto from a “buy” rating to a “strong-buy” rating and set a $116.55 price target on the stock in a research report on Monday, June 27th. Jefferies Group restated a “buy” rating on shares of Monsanto in a research report on Wednesday, June 29th. Deutsche Bank AG restated a “buy” rating and issued a $118.00 price target on shares of Monsanto in a research report on Thursday, June 30th. Finally, Piper Jaffray Cos. dropped their target price on shares of Monsanto from $127.00 to $118.00 and set an “overweight” rating on the stock in a research report on Thursday, June 30th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. Monsanto has a consensus rating of “Buy” and an average target price of $114.65.

The company’s 50 day moving average is $104.39 and its 200-day moving average is $101.78. The firm has a market cap of $44.69 billion, a price-to-earnings ratio of 34.17 and a beta of 1.19.

Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.09. The firm earned $2.56 billion during the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. Monsanto’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.19) EPS. On average, analysts anticipate that Monsanto Co. will post $4.89 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be given a $0.54 dividend. This represents a $2.16 annualized dividend and a dividend yield of 2.12%. The ex-dividend date is Wednesday, October 5th. Monsanto’s dividend payout ratio is presently 71.05%.

Institutional investors have recently bought and sold shares of the company. FMR LLC raised its position in Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock valued at $1,715,960,000 after buying an additional 4,851,499 shares in the last quarter. Third Point LLC acquired a new stake in Monsanto during the second quarter valued at approximately $206,820,000. Carmignac Gestion acquired a new stake in Monsanto during the second quarter valued at approximately $197,555,000. TIAA CREF Investment Management LLC increased its stake in Monsanto by 50.4% in the second quarter. TIAA CREF Investment Management LLC now owns 4,658,464 shares of the company’s stock valued at $481,732,000 after buying an additional 1,560,646 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. increased its stake in Monsanto by 205.6% in the second quarter. Adage Capital Partners GP L.L.C. now owns 1,705,121 shares of the company’s stock valued at $176,327,000 after buying an additional 1,147,200 shares during the last quarter. 79.02% of the stock is owned by hedge funds and other institutional investors.

Related posts

Leave a Comment